HR Healthcare Realty Trust Incorporated

Northside Capital Management LLC reduced its stake in Healthcare Realty Trust Incorporated (NYSE:HR) by 23.7% in Q3, selling 235,043 shares and retaining 755,329 shares valued at approximately $13.62 million. Healthcare Realty Trust exceeded Q3 earnings and revenue estimates but reported negative net margin and return on equity, with analysts holding a consensus "Hold" rating and a price target of $18.89. The company also announced a quarterly dividend of $0.24 per share, resulting in a 5.6% yield.

Healthcare Realty Trust (NYSE:HR) has an average "Hold" rating from eleven analysts, with a 12-month average price target of $18.89. The company recently beat Q3 EPS estimates at $0.41 but saw revenue dip 6.2% year-over-year, and it offers a quarterly dividend yielding approximately 5.6%. Key analyst updates include Royal Bank of Canada initiating coverage with a "sector perform" rating and Cantor Fitzgerald starting with an "overweight" rating.

Cantor Fitzgerald reiterated its Overweight rating and $23.00 price target for Healthcare Realty Trust (NYSE:HR), citing favorable timing for the company’s planned asset sales and a 32% upside from its current price. Despite recent earnings shortfalls, the firm highlighted the company's 33 consecutive years of dividend payments, a 5.53% yield, and improved customer relationships due to property management restructuring. Cantor Fitzgerald sees medical office properties as an attractive "safe haven" in a decelerating but stable economy.

Cantor Fitzgerald has reiterated its Overweight rating and $23.00 price target on Healthcare Realty Trust (NYSE:HR), citing favorable timing for the company’s planned asset sales and positive management performance. The firm views medical office properties as an attractive "safe haven" and expects the company to perform well in a stable economic environment, despite a recent shortfall in Q3 2025 earnings per share and revenue.

The California Public Employees Retirement System recently reduced its stake in Healthcare Realty Trust (NYSE:HR) by 19.5% during Q2, now holding 1,323,389 shares valued at $20.99 million. Healthcare Realty Trust maintains a "Hold" rating from analysts with an average price target of $18.89, trading at approximately $17.35, and offering a 5.5% dividend yield. The company reported Q3 earnings of $0.41 EPS, surpassing estimates, and forecasts FY2025 EPS between $1.59 and $1.60.

Daiwa Securities Group Inc. reduced its stake in Healthcare Realty Trust Incorporated (NYSE:HR) by 1.2% in Q2 2025, selling 146,097 shares and now holding 12,280,355 shares valued at approximately $194.8 million. The real estate investment trust reported Q3 EPS of $0.41, beating estimates, and announced a quarterly dividend of $0.24, representing an annualized yield of 5.6%. The company has a consensus "Hold" rating from analysts with an average target price of $18.89.